Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Cancer-Related Fatigue
NCT00758407Phase 3Completed
- Sponsor
- Medice
- Start
- Aug 2006
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate in cancer-related fatigue (CRF), sponsored by Medice. Started Aug 2006; status: completed.
02
Drugs
methylphenidate
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT00758407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00758407.